tiprankstipranks
Haemonetics Corp. (HAE)
NYSE:HAE
US Market

Haemonetics (HAE) Income Statement

Compare
397 Followers

Haemonetics Income Statement

Last quarter (Q3 2025), Haemonetics's total revenue was $348.54M, an increase of 3.66% from the same quarter last year. In Q3, Haemonetics's net income was $37.49M. See Haemonetics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 24Jun 23Jun 22Jun 21Mar 20
Total Revenue
$ 1.31B$ 1.17B$ 993.20M$ 870.46M$ 988.48M
Gross Profit
$ 691.55M$ 615.10M$ 505.50M$ 397.84M$ 484.51M
Operating Expenses
$ 526.66M$ 459.06M$ 433.78M$ 339.88M$ 330.56M
Depreciation and Amortization
$ 97.22M$ 93.31M$ 97.75M$ 84.29M$ 110.29M
EBITDA
$ 265.58M$ 249.34M$ 178.50M$ 142.25M$ 264.24M
Operating Income
$ 164.88M$ 156.03M$ 80.75M$ 57.96M$ 153.95M
Other Income/Expenses
$ -13.02M$ -14.63M$ -17.12M$ 14.95M$ -16.20M
Pretax Income
$ 151.87M$ 141.40M$ 63.63M$ 72.91M$ 87.15M
Net Income
$ 117.56M$ 115.40M$ 43.38M$ 79.47M$ 76.53M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ 2.32$ 2.27$ 0.85$ 1.57$ 1.51
Diluted EPS
$ 2.29$ 2.24$ 0.84$ 1.55$ 1.48
Weighted Average Shares Outstanding
50.71M 50.78M 51.05M 50.69M 50.69M
Weighted Average Shares Outstanding (Diluted)
51.40M 51.42M 51.35M 51.29M 51.81M
Currency in USD

Haemonetics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis